Literature DB >> 22689688

Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome.

Evangelos Terpos1, Bouchra Asli, Dimitrios Christoulas, Jean-Claude Brouet, Efstathios Kastritis, Michel Rybojad, Djaouida Bengoufa, Meletios A Dimopoulos, Jean Paul Fermand.   

Abstract

Schnitzler syndrome is a rare plasma cell disorder the pathogenesis of which is still not fully understood. We evaluated the circulating levels of four major angiogenic cytokines (VEGF, angiogenin, angiopoietin-1 and angiopoietin-2) and six bone remodeling markers (sRANKL, osteoprotegerin, dickkopf-1, CTX, osteocalcin and bone-specific alkaline phosphatase-bALP) in 13 patients with Schnitzler syndrome. At diagnosis, patients had elevated angiogenic cytokines. The mean VEGF levels were almost 3.5-fold higher in Schnitzler syndrome compared to controls, while 10 of 13 patients had higher VEGF than the upper control value. Successful treatment led to a significant reduction in VEGF. Patients with Schnitzler syndrome had increased bone formation (high bALP, osteocalcin and osteoprotegerin) which was not balanced by an increase in bone resorption (normal CTX and sRANKL). These data support a role for VEGF as a new minor criterion in the diagnosis and follow up of Schnitzler syndrome, while the uncoupling of bone remodeling in favor of bone formation justifies the presence of bone densification.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22689688      PMCID: PMC3487443          DOI: 10.3324/haematol.2012.067306

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Effect of immune cytokines on bone.

Authors:  P Stashenko; M S Obernesser; F E Dewhirst
Journal:  Immunol Invest       Date:  1989 Jan-May       Impact factor: 3.657

2.  Schnitzler syndrome: a case report of successful treatment using the anti-CD20 monoclonal antibody rituximab.

Authors:  K M Ramadan; H A Eswedi; M R El-Agnaf
Journal:  Br J Dermatol       Date:  2007-03-13       Impact factor: 9.302

3.  Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin/receptor activator of nuclear factor-{kappa}B (RANK) ligand/RANK system.

Authors:  Xin-Hua Liu; Alexander Kirschenbaum; Shen Yao; Alice C Levine
Journal:  Endocrinology       Date:  2004-12-23       Impact factor: 4.736

4.  Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.

Authors:  Efstathios Kastritis; Evangelos Terpos; Athanasios Anagnostopoulos; Irini Xilouri; Meletios Athanasios Dimopoulos
Journal:  Clin Lymphoma Myeloma       Date:  2006-07

5.  Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.

Authors:  Evangelos Terpos; Richard Szydlo; Jane F Apperley; Evdoxia Hatjiharissi; Marianna Politou; John Meletis; Nora Viniou; Xenophon Yataganas; John M Goldman; Amin Rahemtulla
Journal:  Blood       Date:  2003-04-10       Impact factor: 22.113

6.  Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenström macroglobulinaemia.

Authors:  Evangelos Terpos; Athanasios Anagnostopoulos; Efstathios Kastritis; Aristotelis Bamias; Konstantinos Tsionos; Meletios-Athanassios Dimopoulos
Journal:  Br J Haematol       Date:  2006-05       Impact factor: 6.998

Review 7.  The Schnitzler syndrome. Four new cases and review of the literature.

Authors:  D Lipsker; Y Veran; F Grunenberger; B Cribier; E Heid; E Grosshans
Journal:  Medicine (Baltimore)       Date:  2001-01       Impact factor: 1.889

8.  Characterization of Dkk1 gene regulation by the osteoblast-specific transcription factor Osx.

Authors:  Chi Zhang; Hui Dai; Benoit de Crombrugghe
Journal:  Biochem Biophys Res Commun       Date:  2012-03-20       Impact factor: 3.575

9.  Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.

Authors:  Athanasios Anagnostopoulos; Vangelis Eleftherakis-Papaiakovou; Efstathios Kastritis; Konstantinos Tsionos; Aristotelis Bamias; John Meletis; Meletios A Dimopoulos; Evangelos Terpos
Journal:  Br J Haematol       Date:  2007-06       Impact factor: 6.998

Review 10.  Blocking IL-1 in systemic inflammation.

Authors:  Charles A Dinarello
Journal:  J Exp Med       Date:  2005-05-02       Impact factor: 14.307

View more
  11 in total

Review 1.  Schnitzler Syndrome: a Review.

Authors:  L Gusdorf; D Lipsker
Journal:  Curr Rheumatol Rep       Date:  2017-08       Impact factor: 4.592

2.  Inhibition of osteogenic differentiation of mesenchymal stem cells by copper supplementation.

Authors:  S Li; M Wang; X Chen; S-F Li; J Li-Ling; H-Q Xie
Journal:  Cell Prolif       Date:  2014-02       Impact factor: 6.831

3.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

4.  [Schnitzler syndrome].

Authors:  F F Gellrich; C Günther
Journal:  Hautarzt       Date:  2018-09       Impact factor: 0.751

5.  Imaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the "hot knees" sign differential diagnosis.

Authors:  Blake D Niederhauser; David Dingli; Robert A Kyle; Michael D Ringler
Journal:  Skeletal Radiol       Date:  2014-03-21       Impact factor: 2.199

Review 6.  Schnitzler's syndrome: lessons from 281 cases.

Authors:  Heleen D de Koning
Journal:  Clin Transl Allergy       Date:  2014-12-05       Impact factor: 5.871

7.  Schnitzler syndrome, a rare autoinflammatory disease. Complete response to IL-1 blockade.

Authors:  Paola Faggioli; Antonio Tamburello; Lucia Roncoroni; Antonino Mazzone
Journal:  Clin Pract       Date:  2017-12-12

Review 8.  The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis.

Authors:  Dongdong Yu; Yikai Cai; Wei Zhou; Jinghao Sheng; Zhengping Xu
Journal:  Dis Markers       Date:  2018-03-15       Impact factor: 3.434

9.  Scavenger receptor class B, type I (Scarb1) deficiency promotes osteoblastogenesis but stunts terminal osteocyte differentiation.

Authors:  Corine Martineau; Olha Kevorkova; Louise Brissette; Robert Moreau
Journal:  Physiol Rep       Date:  2014-10-02

Review 10.  Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.

Authors:  Jonas Paludo; Stephen M Ansell
Journal:  F1000Res       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.